Carolina Eye Participates in FDA Approved Medical Device Study

April 7th, 2014 by Carolina Eye Associates

Carolina Eye Participates in FDA Approved Medical Device Study

 

Carolina Eye Associate’s, Tarra Millender, MD, Glaucoma and Cataract Specialist will be participating in a prospective, single-arm multicenter registry of subjects implanted with Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100 stents.  The purpose of this study is to assess the safety of an approved FDA medical device that is implanted into the eye and designed to reduce eye pressure in patients with glaucoma.  The study is being sponsored by Glaukos Corporation, a company working in the field of glaucoma research.

The study device is known as Glaukos® iStent® Trabecular Micro-Bypass Stent Model GTS100 stents.  The study device is the smallest medical device to be implanted in the human body.

The study stent, when placed in the eye, may help lower intraocular pressure.  It does this by providing a channel for fluid to move out of the anterior chamber of the eye.  Less fluid in the chamber means lower pressure. This may help reduce intraocular pressure, a risk factor for the progression of glaucoma.

Carolina Eye is currently seeking participants for the study who have been diagnosed with mild to moderate open-angle glaucoma, and are taking medications to control the eye pressure in the eye.  In addition, the participant must have a cataract that requires surgery.

If you think you may be a candidate for the study contact Carolina Eye Associates, Lisa Fulghum, Research Clinical Trials Coordinator, 910-295-2100 ext. 881 or lisa.fulghum@carolinaeye.com

Comments are closed.

North Carolina WordPress web design and WordPress web hosting by ConnectNC, Inc.